Learn more

ACEA BIOSCIENCES INC

Overview
  • Total Patents
    157
  • GoodIP Patent Rank
    25,175
  • Filing trend
    ⇩ 40.0%
About

ACEA BIOSCIENCES INC has a total of 157 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are PSYCHIATRIC GENOMICS INC, SATO YAKUGAKU KENKYUSHO KK and BARNES CHRISTOPHER.

Patent filings per year

Chart showing ACEA BIOSCIENCES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Xiaobo 143
#2 Xu Xiao 117
#3 Xi Biao 58
#4 Mao Long 51
#5 Zhao Li 49
#6 Li Nan 40
#7 Abassi Yama A 34
#8 Abassi Yama 19
#9 Chen Ye 15
#10 An Haoyun 14

Latest patents

Publication Filing date Title
WO2018161063A1 METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES
CA3030966A1 Optical detection system for flow cytometer, flow cytometer system and methods of use
US2017315122A1 Optical detection system for flow cytometer, flow cytometer system and methods of use
US2017269062A1 Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
CN108473926A The cellular matrix impedance monitoring of cancer cell
US2016097707A1 Methods of collecting cells from multi-well plates for use in flow cytometry
US2015140577A1 Optical engine for flow cytometer, flow cytometer system and methods of use
US2015185206A1 Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology
US2015133457A1 Heterocyclic compounds and uses thereof
KR20160037929A Heterocyclic compounds and uses thereof
US2014203818A1 System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties
US2015210702A1 Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
NZ629807A Novel pyrrolopyrimidine compounds as inhibitors of protein kinases
US2014038940A1 EGFR modulators and uses thereof
EP2802568A1 Heterocyclic compounds and uses as anticancer agents.
CA2853093A1 System and method for detecting multiple-excitation-induced light in a flow channel
CA2853083A1 Device for splitting light into components having different wavelength ranges and methods of use
WO2013081651A1 Co-culture device assembly
WO2012097196A1 Pyrazolopyrimidine derivatives and uses as anticancer agents
WO2011146531A1 Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments